The SSAI fully supports the suspension of hydroxyethyl-starch solutions commissioned by the European Medicines Agency.
作者信息
Laake J H, Tønnessen T I, Chew M S, Lipcsey M, Hjelmqvist H, Wilkman E, Pettilä V, Hoffmann-Petersen J, Møller M H
机构信息
Department of Anaesthesiology, Division of Critical Care and Emergencies, Oslo University Hospital, Oslo, Norway.
Department of Anaesthesia and Intensive Care, Medical and Health Sciences, Linköping University, Linköping, Sweden.
出版信息
Acta Anaesthesiol Scand. 2018 Jul;62(6):874-875. doi: 10.1111/aas.13120. Epub 2018 Apr 16.
Abstract
摘要
相似文献
1
The SSAI fully supports the suspension of hydroxyethyl-starch solutions commissioned by the European Medicines Agency.SSAI完全支持欧洲药品管理局委托暂停羟乙基淀粉溶液的使用。
Acta Anaesthesiol Scand. 2018 Jul;62(6):874-875. doi: 10.1111/aas.13120. Epub 2018 Apr 16.
2
[Hydroxyethyl starch: Statement of the Presidents of DGAI and the BDA and the President of the DAAF].[羟乙基淀粉：德国麻醉与重症监护医学学会（DGAI）、德国医师协会（BDA）主席及德国麻醉、重症监护、急诊医学和疼痛医学学会（DAAF）主席声明]
Anasthesiol Intensivmed Notfallmed Schmerzther. 2013 Jul;48(7-8):437. doi: 10.1055/s-0033-1352487. Epub 2013 Aug 8.
3
Open letter to the Executive Director of the European Medicines Agency concerning the licensing of hydroxyethyl starch solutions for fluid resuscitation.致欧洲药品管理局执行主任的公开信：关于羟乙基淀粉溶液用于液体复苏的许可问题
Br J Anaesth. 2014 Mar;112(3):595-600. doi: 10.1093/bja/aeu025.
4
[Decision of the European Medicines Agency on hydroxyethyl starch : Important step towards therapeutic and legal security].
Anaesthesist. 2013 Nov;62(11):869-70. doi: 10.1007/s00101-013-2268-5.
5
Starch solutions in Australia: the empire strikes back.澳大利亚的淀粉溶液：帝国反击。
Crit Care Resusc. 2013 Dec;15(4):253-4.
6
Hydroxyethyl starch solutions and patient harm.羟乙基淀粉溶液与患者伤害
Lancet. 2018 Feb 24;391(10122):736. doi: 10.1016/S0140-6736(18)30255-1. Epub 2018 Feb 12.
7
Why hydroxyethyl starch solutions should NOT be banned from the operating room.为何羟乙基淀粉溶液不应被禁止用于手术室。
Anaesthesiol Intensive Ther. 2014 Nov-Dec;46(5):336-41. doi: 10.5603/AIT.2014.0057.
8
Intravenous starches: is suspension the best solution?静脉注射淀粉类物质：混悬液是最佳解决方案吗？
Anesth Analg. 2014 Sep;119(3):731-736. doi: 10.1213/ANE.0000000000000186.
9
Deleterious renal effects of hydroxyethyl starch 130/0.4 and 200/0.5 solutions.羟乙基淀粉130/0.4溶液和200/0.5溶液对肾脏的有害影响。
Eur J Anaesthesiol. 2007 Oct;24(10):892-3. doi: 10.1017/s0265021507000786.
10
Persistent pruritus after pentastarch infusions in intensive care patients.重症监护患者输注羟乙基淀粉后持续瘙痒
Anaesthesia. 2000 May;55(5):494-5. doi: 10.1046/j.1365-2044.2000.01425-10.x.
引用本文的文献
1
Patient-important outcomes and core outcome sets: increased attention needed!患者重要结局与核心结局集：需要更多关注！
Br J Anaesth. 2019 Apr;122(4):408-410. doi: 10.1016/j.bja.2019.02.007. Epub 2019 Feb 23.
2
Starch Wars-New Episodes of the Saga. Changes in Regulations on Hydroxyethyl Starch in the European Union.淀粉之战——传奇新篇章。欧盟羟乙基淀粉法规的变化
Front Vet Sci. 2019 Jan 18;5:336. doi: 10.3389/fvets.2018.00336. eCollection 2018.
3
Hydroxyethyl starch: the Paradigm of Eminence-Based Versus Evidence-Based Medicine-1.羟乙基淀粉：基于卓越与基于证据的医学范式对比-1
Turk J Anaesthesiol Reanim. 2018 Jun;46(3):165-167. doi: 10.5152/TJAR.2018.030618. Epub 2017 Jun 1.
本文引用的文献
1
Fluid therapy and outcome: a prospective observational study in 65 German intensive care units between 2010 and 2011.液体治疗与预后：2010年至2011年在65个德国重症监护病房进行的一项前瞻性观察研究。
Ann Intensive Care. 2018 Feb 17;8(1):27. doi: 10.1186/s13613-018-0364-z.
2
Hydroxyethyl starch solutions and patient harm.羟乙基淀粉溶液与患者伤害
Lancet. 2018 Feb 24;391(10122):736. doi: 10.1016/S0140-6736(18)30255-1. Epub 2018 Feb 12.
3
Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function.羟乙基淀粉（HES）与其他液体疗法：对肾功能的影响。
Cochrane Database Syst Rev. 2013 Jul 23;2013(7):CD007594. doi: 10.1002/14651858.CD007594.pub3.
4
Colloids versus crystalloids for fluid resuscitation in critically ill patients.胶体液与晶体液用于危重症患者液体复苏的比较
Cochrane Database Syst Rev. 2013 Feb 28(2):CD000567. doi: 10.1002/14651858.CD000567.pub6.
5
Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis.羟乙基淀粉给药与需要容量复苏的危重症患者死亡率和急性肾损伤的关系：系统评价和荟萃分析。
JAMA. 2013 Feb 20;309(7):678-88. doi: 10.1001/jama.2013.430.
6
Safety of modern starches used during surgery.手术中使用的现代淀粉类物质的安全性。
Anesth Analg. 2013 Jan;116(1):35-48. doi: 10.1213/ANE.0b013e31827175da. Epub 2012 Oct 31.
7
Hydroxyethyl starch or saline for fluid resuscitation in intensive care.羟乙基淀粉或生理盐水用于重症监护中的液体复苏。
N Engl J Med. 2012 Nov 15;367(20):1901-11. doi: 10.1056/NEJMoa1209759. Epub 2012 Oct 17.
8
Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis.羟乙基淀粉 130/0.42 与醋酸林格氏液治疗严重脓毒症的比较。
N Engl J Med. 2012 Jul 12;367(2):124-34. doi: 10.1056/NEJMoa1204242. Epub 2012 Jun 27.
9
Effect of hydroxyethyl starch on bleeding after cardiopulmonary bypass: a meta-analysis of randomized trials.羟乙基淀粉对体外循环后出血的影响：随机试验的荟萃分析。
J Thorac Cardiovasc Surg. 2012 Jul;144(1):223-30. doi: 10.1016/j.jtcvs.2012.04.009. Epub 2012 May 9.
10
Preferences for colloid use in Scandinavian intensive care units.斯堪的纳维亚重症监护病房中胶体使用的偏好
Acta Anaesthesiol Scand. 2008 Jul;52(6):750-8. doi: 10.1111/j.1399-6576.2008.01690.x.
Zotero 插件